Science Media Centre

Science Media Centre

Reflections On Science

PHARMAC needs funding boost – Dr Francis Hunter

John Kerr posted in on March 7th, 2016.

Writing on* the University of Auckland’s Dr Francis Hunter outlines the situation PHARMAC and the Government face over the melanoma drug Keytruda. An excerpt (read in full here): ‘Real, urgent’ plight for melanoma patients hoping for better Keytruda funding Pharmac’s assignment of a low-funding priority to pembrolizumab (Keytruda) for advanced melanoma has brought cancer drug […]

PHARMAC not to fund melanoma drug – In the News

John Kerr posted in on December 3rd, 2015.

PHARMAC’s decision not to fund melanoma treatment pembrolizumab – marketed as Keytruda – has been widely covered in the media. Public pressure to fund the drug  increased in September this year following coverage of impressive recoveries attributed to the treatment, and registration of the drug with MedSafe. However according to PHARMAC’s analysis of the available evidence, […]

Medicinal cannabis debated

John Kerr posted in on May 13th, 2014.

TVNZ’s Sunday programme explored the issue of medicinal marijuana this weekend, interviewing Kiwi parents who believe medicinal cannabis is the most effective treatment for severe epilepsy caused by Dravet Syndrome. You can watch the full segment here. The story comes after a a Health Select Committee report on medical cannabis, published last week, recommended no […]

Continue reading “Medicinal cannabis debated

Drug funding key issue at conference

John Kerr posted in on August 2nd, 2013.

Academics, advocates, patients  and politicians wrestled over the legal, ethical and scientific issues surrounding the funding of treatments for suffers of rare disorders at one-day seminar in Wellington this week, The seminar, titled Abandoned? Rare disease, specialised medicines and the politics of access, was held by the New Zealand Organisation for Rare Disorders. The event […]

Copyright 2018 Science Media Centre (New Zealand)

Disclaimer | Privacy Policy